Biomedical Park It mainly focuses on bioengineering, biochemical medicine, modern Chinese medicine, and medical devices, providing "one-stop" services for research and development and industrial value-added services of biomedical enterprises. It is an important symbol of the transformation from a comprehensive incubator to a professional incubator in the construction of the park's entrepreneurial incubation system, and gathers powerful policy resources for the entrepreneurial development of biomedical enterprises.
In 2006, the development of China's biopharmaceutical industry still maintained a steady growth rate of about 15%. The income of biopharmaceutical enterprises increased significantly, but the profit growth slowed down significantly. The competition tended to new technologies and new fields. Experts said that for the current domestic biomedical enterprises, it is crucial to have innovative ability and expand financing channels.

The biomedicine park is mainly composed of three functional areas, namely, research and development zone, enterprise incubation zone, production and trade zone, and related supporting systems.
　　1． Research and development zone Its main task is to research and develop new drugs and other pharmaceutical products with independent intellectual property rights. Build a "Biomedical Joint Research Institute" in the research and development zone, attract domestic and foreign research institutions or enterprises to establish a batch of medical research and development institutions, attract and gather excellent medical science and technology talents at home and abroad, make the research and development zone become an innovation base for biological and medical technology development, a center for the gathering and cultivation of excellent talents, and a bridge for international scientific and technological cooperation.
　　2． Business Incubation Zone Its main task is to incubate emerging pharmaceutical enterprises. Establish a complete set of public R&D platforms and business incubation facilities to provide first-rate, all-round and professional security services and condition support for institutions and enterprises engaged in technology incubation and pilot test in biotechnology and medicine, so as to make them become an incubation base for biotechnology and medicine technology achievements and projects.
　　3． Production and trade zone Its main task is to engage in the production and trade of drugs and other pharmaceutical products. Establish a modern drug production center, logistics center, GMP workshop conforming to international standards, and a large pharmaceutical distribution enterprise conforming to GSP standards. By attracting, cultivating and transforming a number of pharmaceutical enterprises, we will develop a new pharmaceutical industry chain with biomedicine as the main body, traditional Chinese medicine and chemical medicine as the supplement, and pharmaceutical trade as the link to build a "pharmaceutical port" in China.
4. Build a complete set of new drug approval, patent application, property right transaction and foreign trade Supporting system And enhance the attraction and core competitiveness of the Biomedical Park.

　　 Planning of Biomedical Park Main measures for construction
The construction of the biomedicine park will be carried out in accordance with the principle of "modernization, scientificalness and internationalization", planning in place in one step and construction in steps. The Ministry of Science and Technology, the Ministry of Commerce, the Ministry of Health, the State Food and Drug Administration and the government will jointly negotiate and cooperate in the construction. The government is responsible for the administrative management of the park, and is fully responsible for the park's construction planning, construction and investment, as well as the formulation and implementation of supporting policies, talent recruitment and technology introduction. The Ministry of Science and Technology is mainly responsible for assisting the park construction planning, guiding and supporting drug research and development, as well as talent and project introduction. The Ministry of Commerce is mainly responsible for guiding foreign investment and foreign trade. The Ministry of Health is mainly responsible for the guidance and consultation of drug research and production priorities and directions. The State Food and Drug Administration is mainly responsible for guiding and supporting drug research, production and circulation.
1. Scientifically plan to build a modern and international biological medicine park. The design and construction shall be carried out in accordance with the high standards of international first-class drug research, development, production and circulation, and the planning shall be put in place at one step and the construction shall be implemented step by step. Formulate the overall plan of the biomedicine park, and implement the construction funds and land; Complete the construction of infrastructure and environmental supporting facilities; Complete the construction of public R&D platform and relevant incubation system.
2. Introduce and cultivate a team of outstanding talents. Attract high-level talents, projects and institutions from abroad, integrate the advantageous resources of relevant domestic R&D institutions, and lay a good foundation for the construction and development of biomedical parks.
3. Diversified investment and increased support for the construction of the park. At the same time of government support, actively guide and support domestic and foreign venture capital and venture capital companies to establish diversified investment systems and support the construction of biomedical parks. Support science and technology institutions and enterprises in the park to actively apply for relevant national science and technology plans and projects.
4. Policy guidance and system innovation. In terms of biomedicine related industrial policies, trade policies, market access policies, etc., take the biomedicine park as a pilot area for comprehensive supporting reforms, explore and establish a policy environment conducive to promoting the healthy development of China's biomedicine industry; Implement national and local preferential policies in the introduction of senior talents, entrepreneurship support, equity incentive, tax preference, etc., and form an innovation and entrepreneurship environment conducive to talent introduction and enterprise growth.

The original research and capital market of China's biomedicine are far behind those of overseas countries, which leads to a situation of low-level repetitive production and vicious competition in China's biomedicine industry.
For the current Chinese biomedical enterprises, "innovation" is the soul of enterprise development. Experts pointed out that we should encourage independent innovation, focus on the industrialization of products with China's independent intellectual property rights, and improve the ability of industrial independent innovation; Focus on solving major problems affecting industrial development, accelerate the development of China's industrial fields with technological foundation and advantages, and form industrial breakthroughs.
In addition, the establishment of a sound high-tech investment market, biological venture capital funds and independent evaluation institutions is the most important capital base for the biomedical industry. The capital flow led by enterprises is the fundamental way out for the development of China's bio pharmaceutical industry. Biomedical R&D enterprises that focus on the development of original technology as their core competitiveness need more support from investors with strategic vision and the government. This is the most urgent issue for the development of China's biomedical industry at present.
China's biopharmaceutical investment should form a structure with enterprises as the main body, and the flow of funds should be targeted at enterprises, attracting managers with professional knowledge background to gather a large number of scientists with different expertise, and spread horizontally on the basis of a patented technology. Industrialization achievements are the crystallization of the collective wisdom of many scientists, and the leaders of the company are management talents who need knowledge capital. The country has clearly put forward the development idea of innovative science and technology with enterprises as the main body, so that capital flows in the right direction, but it takes time to change. However, private capital still stays on the original concept, still focusing on university scientists, trying to attract more funds with them as the signboard.